Surrozen Return on Equity

Surrozen (SRZN) currently reports a ROE of 77.32%. That is above the Healthcare sector average of 29.33%. Use the charts on this page to explore Surrozen's ROE history and peer comparisons.

Surrozen's ROE of 77.32% is higher than the Healthcare sector average of 29.33%. That is roughly 163.6% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Surrozen's current 77.32% should be judged against Healthcare norms (sector average: 29.33%) and against SRZN's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 77.32%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 29.33%. From there, open related valuation or income-statement pages for Surrozen, and consider following SRZN for alerts when major investors trade the stock.

Surrozen is classified in the Healthcare sector. On ROE, it currently shows 77.32% versus a sector average near 29.33%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SRZN with unrelated industries.